PARLIAMENTARY WRITTEN QUESTION
Developing Countries: Disease Control (5 January 2016)

Whilst the Ross Fund is not directly focused on HIV and AIDS, the UK continues to invest in research on HIV and AIDS. This includes research into understanding the structural drivers that can increase HIV (including gender inequality, stigma and limited livelihood opportunities), HIV prevention technologies (such as microbicides and vaccines) and studies to identify cost-effective ways to deliver HIV services.

The Ross Fund will target infectious diseases including malaria, diseases with epidemic potential, neglected tropical diseases which affect over a billion people globally, and antimicrobial resistance which poses a substantial and growing threat to global health. The goal of the Ross fund is to develop, test and deliver a range of new products (including vaccines, drugs and diagnostics) to help combat these diseases in developing countries.